Senate Looks To Regulate Dietary Supplements
The bill, known as “The Dietary Supplement and Nonprescription Drug Consumer Protection Act,” would give companies 15 business days to report life-threatening conditions, hospitalizations, disabilities, birth defects and congenital anomalies to the Food and Drug Administration. It would also require manufacturers to keep records of such serious adverse effects for six years.
Records of less serious side...
Already a subscriber? Click here to login